FDA
-
-
-
-
-
-
-
Revelation Biosciences Inc. Announces Safety Monitoring Committee Recommendation for Continuing Evaluation of REVTx-99b for the Treatment of Allergic Rhinitis
-
-
-
-
-
-
-
Revelation Biosciences Raises $7.76 Million in Equity Financing
-
-
-
-
327,059 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

